POU5F1 and prostate carcinoma: In the context of prostate cancer, aberrant activation of this pathway has been linked to disease progression, therapy resistance, and maintenance of cancer stem-like cells, potentially through interactions with pluripotency factors like OCT4 [55,56,57].